More from ETFs
My portfolio definitely isn't sexy as it is focused more on preserving capital than aggressively trying to grow it.
History indicates the Nasdaq 100's outperformance versus the small-cap Russell 2000 could continue for a bit, but the tech-heavy index is likely on a downward slope.
It's possible these are just blips, but along with the dollar, bonds, oil itself and the Transports, this is where my focus is.
Not all the news from the small biotech space is bad. One company in particular already has been gaining the attention of investors.